Iovance Biotherapeutics, Inc. (IOVA)
3.48
+0.03
(+0.87%)
USD |
NASDAQ |
May 18, 12:45
Iovance Biotherapeutics Market Cap : 1.554B for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 199.32M |
| BioCryst Pharmaceuticals, Inc. | 2.286B |
| Plus Therapeutics, Inc. | 38.84M |
| Perspective Therapeutics, Inc. | 420.83M |
| AVITA Medical, Inc. | 128.34M |
Market Cap Related Metrics
| PS Ratio | 4.643 |
| Price to Book Value | 2.153 |
| Price | 3.48 |
| Earnings Yield | -27.30% |